Polar Asset Management Partners’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-400
| Closed | -$420K | – | 742 |
|
|
2024
Q3 | $420K | Sell |
400
-900
| -69% | -$946K | 0.01% | 448 |
|
|
2024
Q2 | $1.37M | Sell |
1,300
-3,720
| -74% | -$3.91M | 0.03% | 343 |
|
|
2024
Q1 | $4.83M | Sell |
5,020
-4,480
| -47% | -$4.31M | 0.08% | 201 |
|
|
2023
Q4 | $8.34M | Sell |
9,500
-16,400
| -63% | -$14.4M | 0.14% | 120 |
|
|
2023
Q3 | $21.3M | Buy |
25,900
+12,500
| +93% | +$10.3M | 0.47% | 48 |
|
|
2023
Q2 | $9.63M | Buy |
+13,400
| New | +$9.63M | 0.17% | 148 |
|
|
2020
Q3 | – | Sell |
-1,280
| Closed | -$798K | – | 651 |
|
|
2020
Q2 | $798K | Buy |
+1,280
| New | +$798K | 0.01% | 263 |
|